Aug. 10, 2005 — The U.S. Food and Drug Administration (FDA) approved in May revisions to safety labeling to advise that prophylactic use of fondaparinux sodium injection is associated with an ...

Are fondaparinux (Arixtra) injections preferable to warfarin (Coumadin) for management of anticoagulation in postoperative hip-fracture patients and those recovering from joint replacement surgery?

HYDERABAD, India & BRISBANE, Australia--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final ...

In patients with NSTE ACS, fondaparinux was not inferior to enoxaparin in reducing the occurrence of death, MI or refractory ischemia at 9 days, and was superior to enoxaparin in reducing death and ...

Mylan Ireland Limited has entered into an agreement to acquire the U.S. rights to Aspen Global’s Arixtra Injection. Arixtra is indicated for the prophylaxis of deep vein thrombosis. Mylan will pay ...

SAN FRANCISCO (MarketWatch) -- GlaxoSmithKline plc said Monday the supplemental new drug application for its anticoagulant drug candidate Arixtra has been accepted for priority review by the Food and ...

LONDON, Sept 3 (Reuters) - GlaxoSmithKline Plc said on Monday that European regulators had approved its anti-clot treatment Arixtra for specific acute coronary syndromes (ACS). ACS conditions affect ...

Novo Nordisk's Frankfurt-listed shares rose 4.5% on Monday after telehealth firm Hims & Hers reversed its launch of a $49 compounded weight-loss pill over the weekend, following legal threats from ...